Fetal Immunity Defends the Brain Before Birth

by Dr Natalie Singh - Health Editor
0 comments

Fetal Immune System: Protecting Against Infections Before Birth

Breaking news from Duke-NUS Medical School reveals that fetuses possess a functional immune system capable of fighting infections long before birth. This groundbreaking discovery challenges previous assumptions and opens exciting possibilities for protecting unborn babies from congenital disorders.

According to the research, published in the prestigious journal *Cell*, fetuses have a complex immune response network that can either protect them from infections or, conversely, cause harmful inflammation in the developing brain.

Congenital disorders, often caused by infections passed from mother to fetus during pregnancy, tragically claim around 240,000 newborn lives annually. Understanding fetal immunity is crucial in combating this global health challenge.

### Key Findings: A Delicate Balance

  • Fetal Immunity: Fetuses possess a functional immune system capable of battling infections early in development.
  • Protective vs. Harmful: Microglia, a type of immune cell found in the brain, protect the developing brain. However, monocytes, another immune cell, can trigger damaging inflammation.
  • Therapeutic Potential: Blocking harmful inflammatory responses with experimental drugs could prevent brain damage caused by infections.

The research team, led by Associate Professor Ashley St John, focused on Zika virus, a pathogen known to cause severe birth defects. Using preclinical models and human brain organoids (mini-brains), they discovered that microglia acted as guardians, limiting viral spread and protecting neurons.

Conversely, monocytes, while drawn to the brain during infection, released excessive nitric oxide synthase-2 (NOS2) coupled with reactive oxygen species. This potent combination caused neuron damage, highlighting the danger of uncontrolled inflammation.

### Turning the Tide: Anti-inflammatory Hope

Remarkably, scientists observed that blocking NOS2 with an experimental drug reduced harmful inflammation induced by monocytes. This breakthrough suggests the potential for developing targeted therapies to protect fetal brains during infections.

“Our findings demonstrate that fetal immune responses can be either protective or harmful. Understanding how different immune cells contribute to fetal immune protection is crucial in our quest to improve pregnancy outcomes,” explained Assoc. Prof. St. John.

Professor Patrick Tan, Senior Vice-Dean for Research at Duke-NUS, emphasized the broader implications of this discovery:

“This research represents a significant step towards mapping the intricate workings of the human immune system, from its earliest stages. Unraveling these complexities has the potential to pave the way for innovative medical interventions and improve global health.”

This exciting research underscores the potential of harnessing fetal immunity for protecting unborn babies. Continued research and clinical trials on this promising avenue hold hope for preventing congenital disorders caused by infections.

Stay informed about the latest developments in fetal health research and support organizations dedicated to improving maternal and child health.

Monocytes, white blood cells produced in the bone marrow, were another type of immune cell that the researchers studied. Credit: Neuroscience News

Related Posts

Leave a Comment